Accès gratuit
Med Sci (Paris)
Volume 22, Numéro 12, Décembre 2006
Page(s) 1081 - 1086
Section M/S revues
Publié en ligne 15 décembre 2006
  1. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997; 278 : 2075–80.
  2. Jordan MS, Singer AL, Koretzky GA. Adaptors as central mediators of signal transduction in immune cells. Nat Immunol 2003; 4 : 110–6.
  3. Ren R, Mayer BJ, Cicchetti P, Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993; 259 : 1157–61.
  4. Deckert M, Tartare-Deckert S, Hernandez J, et al. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity 1998; 9 : 595–605.
  5. Bell SM, Shaw M, Jou YS, et al. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer. Genomics 1997; 44 : 163–70.
  6. Foucault I, Le Bras S, Charvet C, et al. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood 2005; 105 : 1106–13.
  7. Maeno K, Sada K, Kyo S, et al. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase. J Biol Chem 2003; 278 : 24912–20.
  8. Songyang Z, Shoelson SE, McGlade J, et al. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol 1994; 14 : 2777–85.
  9. Kendrick TS, Lipscombe RJ, Rausch O, et al. Contribution of the membrane-distal tyrosine in intracellular signaling by the granulocyte colony-stimulating factor receptor. J Biol Chem 2004; 279 : 326–40.
  10. Sada K, Miah SM, Maeno K, et al. Regulation of FcεRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells. Blood 2002; 100 : 2138–44.
  11. Jevremovic D, Billadeau DD, Schoon RA, et al. Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. J Immunol 2001; 166 : 7219–28.
  12. Qu X, Kawauchi-Kamata K, Miah SM, et al. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor. Biochemistry 2005; 44 : 3891–8.
  13. Foucault I, Liu YC, Bernard A, Deckert M. The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function. J Biol Chem 2003; 278 : 7146–53.
  14. Miah SM, Hatani T, Qu X, et al. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function. Genes Cells 2004; 9 : 993–1004.
  15. Turner M, Billadeau DD. VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat Rev Immunol 2002; 2 : 476–86.
  16. Wu J, Motto DG, Koretzky GA, Weiss A. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 1996; 4 : 593–602.
  17. Zakaria S, Gomez TS, Savoy DN, et al. Differential regulation of TCR-mediated gene transcription by Vav family members. J Exp Med 2004; 199 : 429–34.
  18. Saborit-Villarroya I, Del Valle JM, Romero X, et al. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing. J Immunol 2005; 175 : 4226–35.
  19. Zollino M, Di Stefano C, Zampino G, et al. Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. Am J Med Genet 2000; 94 : 254–61.
  20. Ueki Y, Tiziani V, Santanna C, et al. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet 2001; 28 : 125–6.
  21. Jones WA. Cherubism: A thumbnail sketch of its diagnosis and a conservative method of treatment. Oral Surg Oral Med Oral Pathol 1965; 20 : 648–53.
  22. Southgate J, Sarma U, Townend JV, et al. Study of the cell biology and biochemistry of cherubism. J Clin Pathol 1998; 51 : 831–7.
  23. Imai Y, Kanno K, Moriya T, et al. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism. Cleft Palate Craniofac J 2003; 40 : 632–8.
  24. Lo B, Faiyaz-Ul-Haque M, Kennedy S, et al. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism. Am J Med Genet 2003; 121A : 37–40.
  25. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 2005; 83 : 170–9.
  26. Li B, Boast S, de los Santos K, et al. Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 2000; 24 : 304–8.
  27. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991; 64 : 693–702.
  28. Mocsai A, Humphrey MB, Van Ziffle JA, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 2004; 101 : 6158–63.
  29. Faccio R, Teitelbaum SL, Fujikawa K, et al. Vav3 regulates osteoclast function and bone mass. Nat Med 2005; 11 : 284–90.
  30. Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002; 20 : 795–823.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.